. . . . "Resistance proportions across 924,635 Escherichia coli isolates from human urinary tract infections reported to the Dutch ISIS-AR surveillance system by 27 laboratories between 2009 and 2020, ranging from 3.2% for ceftazidime to 38.8% for amoxicillin or ampicillin. 82.0% of isolates came from general practices and 77.2% from female patients." . . . . "Resistance levels in human urinary Escherichia coli isolates" . . . . . . "evidence" . "high throughput evidence" . "Lapo Mughini-Gras" . "Anouk P. Meijs" . "Eelco Franz" . "2026-09-09T09:03:19Z"^^ . . . . . . "Evidence: Resistance levels in human urinary Escherichia coli isolates" . . . . . . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAq/UT4mEO8sT0Co9F/EBYsf3anJLEeBH0q+JCXbo7FCo+FUXSnic/50bSY5InZoQXt6Qc9QvJgiCe3b/OUr12QqUCQhrofuvRjCusikunl0HFMTLohACpWjtpeq2BY4G/2Vb/EtcgSU7S8SACDt8IEM3UYwFki0HBw1aLbbbVddyIaS7W7dBDye50WuWV6Tt2n4B+fCAwLzLilR44rJom+K93GF2IGH20l83edBVMm7W1xuRwCglHmtu5aM3v3VZfxGoveZEbtMp8LsGFO0IaLOGKi072OocbNZQ08KWNrLLCWwAN79xjb9gKK75AmVcgmQDInqY9P9mBKo85zhxeBwIDAQAB" . "g7eH5qgtIN27lrzxO6txl97IgVXHC1cma8Al/1OlQiHFMVTyQgjTDw5fnM4FnRstXukf2ECpV6aWxqT5Sije+r0aRW6R6wtDQTrz+1c7FpFliUuWKshYLV9vIE/K8foEWUvyoARiWvzA4vVLmpJ3b4eRQJNdlS1pDlnoI7exIW6VcikFWImDZ8vPa58RxHcXMZWq5UHqR39NQIyOqxR07nWUZXWNvxRzC4cF0PWjnjKXYHEbrrOaAYIRwSLTko8+9sdpCBf6IJu88veYnR9gTqLVgcCosheuTjNUswskooiQCpyqO5zvlNGS0122/GZjuRFO4zMCMMChdQX5gLczKQ==" . . . "ZonMw Bot" .